Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
- The Trump administration's cuts impacted the Food and Drug Administration by eliminating employees who review food safety and medical devices.
- Probationary employees at the FDA received job elimination notifications, as reported by three FDA staffers who spoke to The Associated Press anonymously.
- The U.S. Department of Health and Human Services announced plans to fire 5,200 probationary employees across its agencies, including the FDA.
- Mitch Zeller, the former FDA director for tobacco, stated that the firings are intended to 'demoralize and undermine the spirit of the federal workforce.
69 Articles
69 Articles
FDA Layoffs in Staff Overseeing Food Safety, Medical Devices, and Tobacco Products
(MedPage Today) — The Trump administration’s effort to slash the size of the federal workforce reached the FDA this weekend, as recently hired employees who review the safety of food ingredients, medical devices, and other products were fired… Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/114252 Author : Publish date : 2025-02-18 16:27:20 Copyright for syndicated content belongs to […]
Cleaning house: Musk fires FDA employees overseeing Neuralink
The cuts raised concerns about the FDA’s ability to efficiently and safely process medical device applications, including those from Neuralink. "It’s intimidating to the FDA professionals who are overseeing Neuralink’s trial," said Victor Krauthamer, a former acting director in the agency’s brain implant trials division.
What new DOGE firings at the FDA could mean for food safety and medical devices
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this weekend, as recently hired employees who review the safety of food ingredients, medical devices, and other products were fired. Probationary employees across the FDA received notices Saturday evening that their jobs were being eliminated, according to three FDA staffers who spoke to The Associated Press on condition of anony…
Coverage Details
Bias Distribution
- 62% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage